Piramal Critical Care, Inc., a subsidiary of Piramal Pharma Limited, has entered into a partnership with Blue-Zone Technologies Ltd. to implement a full lifecycle solution for capturing, collecting, and recycling waste anesthetic gases. By combining Blue-Zone’s innovative Phoenix Deltasorb technology with Piramal’s global manufacturing and distribution capabilities, the collaboration aims to help healthcare providers reduce the environmental impact of volatile anesthetics while ensuring these essential medicines remain available for patient care worldwide.
Health Technology Insights: Steven Gonzalez on Leadership Presence and Future of Work
Blue-Zone is currently seeking regulatory approval in Europe for its Phoenix Deltasorb residual anesthetic gas capture system. In the meantime, the technology will be offered to Piramal Critical Care’s European customers, beginning in France and Germany. Blue-Zone will manage all aspects of the supply and operation of its systems within healthcare facilities, while Piramal will process the recovered gases to produce Sevoflurane USP for human use at its Canadian facilities. The partners expect the program to expand to additional regions in the near future, increasing both the capture and recycling of residual anesthetic gases and the production of Sevoflurane from these recovered materials.
Health Technology Insights: Health Technology Insights: Latest News And Innovations – Roundup 3 February 2026
Jeff Hampton, President and Chief Operating Officer of Piramal Critical Care, said that the company is proud to collaborate with Blue-Zone to bring this innovative solution to hospitals. He emphasized that the initiative not only reduces waste and supports environmental sustainability but also allows hospitals to select inhaled anesthetics that best meet patient care needs. Hampton noted that Piramal remains committed to balancing clinical performance with environmental responsibility and ensuring that patients continue to receive safe and effective anesthesia.
Inhaled anesthetics are critical for patient care worldwide, and as a leading manufacturer of general anesthesia products, Piramal Pharma continues to support healthcare systems by integrating sustainable practices into essential medical treatments. The partnership demonstrates a shared focus on innovation, environmental stewardship, and patient-centered care.
Health Technology Insights: TransLogic Launches Secure Tube System Monitoring
To participate in our interviews, please write to our HealthTech Media Room at info@intentamplify.com
